Borderline Resectable and Locally Advanced Pancreatic Cancer: FDG PET/MRI and CT Tumor Metrics for Assessment of Pathologic Response to Neoadjuvant Therapy and Prediction of Survival.

Overview of attention for article published in American Journal of Roentgenology, October 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 6 news outlets
blogs: 1 blog
twitter: 21 X users

facebook: 1 Facebook page
video: 1 YouTube creator
podcasts: 1 podcast

Readers on

mendeley: 54 Mendeley

So far, Altmetric has seen 33 X posts from 21 X users, with an upper bound of 87,906 followers.

RT @AJR_Radiology: Borderline resectable and locally advanced pancreatic cancer: FDG PET/MRI and CT tumor metrics for assessment of patholo…

BACKGROUND. Imaging biomarkers of response to neoadjuvant therapy (NAT) for pancreatic ductal adenocarcinoma (PDA) are needed to optimize treatment decisions and long-term outcomes. OBJECTIVE. The purpose of this study was to inves…https://t.co/utlcNxavog…

Borderline resectable and locally advanced pancreatic cancer: FDG PET/MRI and CT tumor metrics for assessment of pathologic response to neoadjuvant therapy and prediction of survival https://t.co/Ljv1AyOjuK https://t.co/lbbwwx6EbG

RT @AJR_Radiology: This week's open access Editor's Choice article finds PET/MRI and CT metrics can help guide post-NAT pancreatic cancer t…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 29 additional X posts.